HuGE Literature Finder
Records
1
-
2
Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors. Neuroendocrinology 2015 Sep . Cros Jerome, Moati Emilie, Raffenne Jerome, Hentic Olivia, Svrcek Magali, de Mestier Louis, Sbidian Emilie, Guedj Nathalie, Bedossa Pierre, Paradis Valerie, Sauvanet Alan, Panis Yves, Ruszniewski Philippe, Couvelard Anne, Hammel Pasc |
The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy. Cancer research 2012 Nov 72 (22): 5683-91. Serra Stefano, Zheng Lei, Hassan Manal, Phan Alexandria T, Woodhouse Linda J, Yao James C, Ezzat Shereen, Asa Sylvia |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: